Cargando…

Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses of pancreatic ductal adenocarcinoma

BACKGROUND: The identification of differentially expressed tumor-associated proteins and genomic alterations driving neoplasia is critical in the development of clinical assays to detect cancers and forms the foundation for understanding cancer biology. One of the challenges in the analysis of pancr...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qing Kay, Hu, Yingwei, Chen, Lijun, Schnaubelt, Michael, Cui Zhou, Daniel, Li, Yize, Lu, Rita Jui-Hsien, Thiagarajan, Mathangi, Hostetter, Galen, Newton, Chelsea J., Jewell, Scott D., Omenn, Gil, Robles, Ana I., Mesri, Mehdi, Bathe, Oliver F., Zhang, Bing, Ding, Li, Hruban, Ralph H., Chan, Daniel W., Zhang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583468/
https://www.ncbi.nlm.nih.gov/pubmed/36266629
http://dx.doi.org/10.1186/s12014-022-09373-x
_version_ 1784813078064398336
author Li, Qing Kay
Hu, Yingwei
Chen, Lijun
Schnaubelt, Michael
Cui Zhou, Daniel
Li, Yize
Lu, Rita Jui-Hsien
Thiagarajan, Mathangi
Hostetter, Galen
Newton, Chelsea J.
Jewell, Scott D.
Omenn, Gil
Robles, Ana I.
Mesri, Mehdi
Bathe, Oliver F.
Zhang, Bing
Ding, Li
Hruban, Ralph H.
Chan, Daniel W.
Zhang, Hui
author_facet Li, Qing Kay
Hu, Yingwei
Chen, Lijun
Schnaubelt, Michael
Cui Zhou, Daniel
Li, Yize
Lu, Rita Jui-Hsien
Thiagarajan, Mathangi
Hostetter, Galen
Newton, Chelsea J.
Jewell, Scott D.
Omenn, Gil
Robles, Ana I.
Mesri, Mehdi
Bathe, Oliver F.
Zhang, Bing
Ding, Li
Hruban, Ralph H.
Chan, Daniel W.
Zhang, Hui
author_sort Li, Qing Kay
collection PubMed
description BACKGROUND: The identification of differentially expressed tumor-associated proteins and genomic alterations driving neoplasia is critical in the development of clinical assays to detect cancers and forms the foundation for understanding cancer biology. One of the challenges in the analysis of pancreatic ductal adenocarcinoma (PDAC) is the low neoplastic cellularity and heterogeneous composition of bulk tumors. To enrich neoplastic cells from bulk tumor tissue, coring, and laser microdissection (LMD) sampling techniques have been employed. In this study, we assessed the protein and KRAS mutation changes associated with samples obtained by these enrichment techniques and evaluated the fraction of neoplastic cells in PDAC for proteomic and genomic analyses. METHODS: Three fresh frozen PDAC tumors and their tumor-matched normal adjacent tissues (NATs) were obtained from three sampling techniques using bulk, coring, and LMD; and analyzed by TMT-based quantitative proteomics. The protein profiles and characterizations of differentially expressed proteins in three sampling groups were determined. These three PDACs and samples of five additional PDACs obtained by the same three sampling techniques were also subjected to genomic analysis to characterize KRAS mutations. RESULTS: The neoplastic cellularity of eight PDACs ranged from less than 10% to over 80% based on morphological review. Distinctive proteomic patterns and abundances of certain tumor-associated proteins were revealed when comparing the tumors and NATs by different sampling techniques. Coring and bulk tissues had comparable proteome profiles, while LMD samples had the most distinct proteome composition compared to bulk tissues. Further genomic analysis of bulk, cored, or LMD samples demonstrated that KRAS mutations were significantly enriched in LMD samples while coring was less effective in enriching for KRAS mutations when bulk tissues contained a relatively low neoplastic cellularity. CONCLUSIONS: In addition to bulk tissues, samples from LMD and coring techniques can be used for proteogenomic studies. The greatest enrichment of neoplastic cellularity is obtained with the LMD technique. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12014-022-09373-x.
format Online
Article
Text
id pubmed-9583468
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-95834682022-10-21 Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses of pancreatic ductal adenocarcinoma Li, Qing Kay Hu, Yingwei Chen, Lijun Schnaubelt, Michael Cui Zhou, Daniel Li, Yize Lu, Rita Jui-Hsien Thiagarajan, Mathangi Hostetter, Galen Newton, Chelsea J. Jewell, Scott D. Omenn, Gil Robles, Ana I. Mesri, Mehdi Bathe, Oliver F. Zhang, Bing Ding, Li Hruban, Ralph H. Chan, Daniel W. Zhang, Hui Clin Proteomics Research BACKGROUND: The identification of differentially expressed tumor-associated proteins and genomic alterations driving neoplasia is critical in the development of clinical assays to detect cancers and forms the foundation for understanding cancer biology. One of the challenges in the analysis of pancreatic ductal adenocarcinoma (PDAC) is the low neoplastic cellularity and heterogeneous composition of bulk tumors. To enrich neoplastic cells from bulk tumor tissue, coring, and laser microdissection (LMD) sampling techniques have been employed. In this study, we assessed the protein and KRAS mutation changes associated with samples obtained by these enrichment techniques and evaluated the fraction of neoplastic cells in PDAC for proteomic and genomic analyses. METHODS: Three fresh frozen PDAC tumors and their tumor-matched normal adjacent tissues (NATs) were obtained from three sampling techniques using bulk, coring, and LMD; and analyzed by TMT-based quantitative proteomics. The protein profiles and characterizations of differentially expressed proteins in three sampling groups were determined. These three PDACs and samples of five additional PDACs obtained by the same three sampling techniques were also subjected to genomic analysis to characterize KRAS mutations. RESULTS: The neoplastic cellularity of eight PDACs ranged from less than 10% to over 80% based on morphological review. Distinctive proteomic patterns and abundances of certain tumor-associated proteins were revealed when comparing the tumors and NATs by different sampling techniques. Coring and bulk tissues had comparable proteome profiles, while LMD samples had the most distinct proteome composition compared to bulk tissues. Further genomic analysis of bulk, cored, or LMD samples demonstrated that KRAS mutations were significantly enriched in LMD samples while coring was less effective in enriching for KRAS mutations when bulk tissues contained a relatively low neoplastic cellularity. CONCLUSIONS: In addition to bulk tissues, samples from LMD and coring techniques can be used for proteogenomic studies. The greatest enrichment of neoplastic cellularity is obtained with the LMD technique. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12014-022-09373-x. BioMed Central 2022-10-20 /pmc/articles/PMC9583468/ /pubmed/36266629 http://dx.doi.org/10.1186/s12014-022-09373-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Li, Qing Kay
Hu, Yingwei
Chen, Lijun
Schnaubelt, Michael
Cui Zhou, Daniel
Li, Yize
Lu, Rita Jui-Hsien
Thiagarajan, Mathangi
Hostetter, Galen
Newton, Chelsea J.
Jewell, Scott D.
Omenn, Gil
Robles, Ana I.
Mesri, Mehdi
Bathe, Oliver F.
Zhang, Bing
Ding, Li
Hruban, Ralph H.
Chan, Daniel W.
Zhang, Hui
Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses of pancreatic ductal adenocarcinoma
title Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses of pancreatic ductal adenocarcinoma
title_full Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses of pancreatic ductal adenocarcinoma
title_fullStr Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses of pancreatic ductal adenocarcinoma
title_full_unstemmed Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses of pancreatic ductal adenocarcinoma
title_short Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses of pancreatic ductal adenocarcinoma
title_sort neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses of pancreatic ductal adenocarcinoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583468/
https://www.ncbi.nlm.nih.gov/pubmed/36266629
http://dx.doi.org/10.1186/s12014-022-09373-x
work_keys_str_mv AT liqingkay neoplasticcellenrichmentoftumortissuesusingcoringandlasermicrodissectionforproteomicandgenomicanalysesofpancreaticductaladenocarcinoma
AT huyingwei neoplasticcellenrichmentoftumortissuesusingcoringandlasermicrodissectionforproteomicandgenomicanalysesofpancreaticductaladenocarcinoma
AT chenlijun neoplasticcellenrichmentoftumortissuesusingcoringandlasermicrodissectionforproteomicandgenomicanalysesofpancreaticductaladenocarcinoma
AT schnaubeltmichael neoplasticcellenrichmentoftumortissuesusingcoringandlasermicrodissectionforproteomicandgenomicanalysesofpancreaticductaladenocarcinoma
AT cuizhoudaniel neoplasticcellenrichmentoftumortissuesusingcoringandlasermicrodissectionforproteomicandgenomicanalysesofpancreaticductaladenocarcinoma
AT liyize neoplasticcellenrichmentoftumortissuesusingcoringandlasermicrodissectionforproteomicandgenomicanalysesofpancreaticductaladenocarcinoma
AT luritajuihsien neoplasticcellenrichmentoftumortissuesusingcoringandlasermicrodissectionforproteomicandgenomicanalysesofpancreaticductaladenocarcinoma
AT thiagarajanmathangi neoplasticcellenrichmentoftumortissuesusingcoringandlasermicrodissectionforproteomicandgenomicanalysesofpancreaticductaladenocarcinoma
AT hostettergalen neoplasticcellenrichmentoftumortissuesusingcoringandlasermicrodissectionforproteomicandgenomicanalysesofpancreaticductaladenocarcinoma
AT newtonchelseaj neoplasticcellenrichmentoftumortissuesusingcoringandlasermicrodissectionforproteomicandgenomicanalysesofpancreaticductaladenocarcinoma
AT jewellscottd neoplasticcellenrichmentoftumortissuesusingcoringandlasermicrodissectionforproteomicandgenomicanalysesofpancreaticductaladenocarcinoma
AT omenngil neoplasticcellenrichmentoftumortissuesusingcoringandlasermicrodissectionforproteomicandgenomicanalysesofpancreaticductaladenocarcinoma
AT roblesanai neoplasticcellenrichmentoftumortissuesusingcoringandlasermicrodissectionforproteomicandgenomicanalysesofpancreaticductaladenocarcinoma
AT mesrimehdi neoplasticcellenrichmentoftumortissuesusingcoringandlasermicrodissectionforproteomicandgenomicanalysesofpancreaticductaladenocarcinoma
AT batheoliverf neoplasticcellenrichmentoftumortissuesusingcoringandlasermicrodissectionforproteomicandgenomicanalysesofpancreaticductaladenocarcinoma
AT zhangbing neoplasticcellenrichmentoftumortissuesusingcoringandlasermicrodissectionforproteomicandgenomicanalysesofpancreaticductaladenocarcinoma
AT dingli neoplasticcellenrichmentoftumortissuesusingcoringandlasermicrodissectionforproteomicandgenomicanalysesofpancreaticductaladenocarcinoma
AT hrubanralphh neoplasticcellenrichmentoftumortissuesusingcoringandlasermicrodissectionforproteomicandgenomicanalysesofpancreaticductaladenocarcinoma
AT chandanielw neoplasticcellenrichmentoftumortissuesusingcoringandlasermicrodissectionforproteomicandgenomicanalysesofpancreaticductaladenocarcinoma
AT zhanghui neoplasticcellenrichmentoftumortissuesusingcoringandlasermicrodissectionforproteomicandgenomicanalysesofpancreaticductaladenocarcinoma